Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 14;114(46):12315-12320.
doi: 10.1073/pnas.1705034114. Epub 2017 Oct 31.

NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage

Affiliations

NOX4-dependent neuronal autotoxicity and BBB breakdown explain the superior sensitivity of the brain to ischemic damage

Ana I Casas et al. Proc Natl Acad Sci U S A. .

Abstract

Ischemic injury represents the most frequent cause of death and disability, and it remains unclear why, of all body organs, the brain is most sensitive to hypoxia. In many tissues, type 4 NADPH oxidase is induced upon ischemia or hypoxia, converting oxygen to reactive oxygen species. Here, we show in mouse models of ischemia in the heart, brain, and hindlimb that only in the brain does NADPH oxidase 4 (NOX4) lead to ischemic damage. We explain this distinct cellular distribution pattern through cell-specific knockouts. Endothelial NOX4 breaks down the BBB, while neuronal NOX4 leads to neuronal autotoxicity. Vascular smooth muscle NOX4, the common denominator of ischemia within all ischemic organs, played no apparent role. The direct neuroprotective potential of pharmacological NOX4 inhibition was confirmed in an ex vivo model, free of vascular and BBB components. Our results demonstrate that the heightened sensitivity of the brain to ischemic damage is due to an organ-specific role of NOX4 in blood-brain-barrier endothelial cells and neurons. This mechanism is conserved in at least two rodents and humans, making NOX4 a prime target for a first-in-class mechanism-based, cytoprotective therapy in the unmet high medical need indication of ischemic stroke.

Keywords: BBB; NOX4; endothelium; neurotoxicity; stroke.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
Role of NOX4 in brain ischemia (blue), hindlimb ischemia (green), and MI (red). (A) Infarct volume in Nox4 KO mice (blue) was reduced compared with the WT mice (*P < 0.05, n = 8). (B) Quantified number of capillaries in the ischemic gastrocnemius muscle was not different between Nox4 KO (green, n = 16) and WT mice (white, n = 22). (C) Quantified number of capillaries in the ischemic adductor muscle did not show a difference between Nox4 KO (green, n = 15) and WT mice (white, n = 19). (D) Blood flow restoration decreased in the Nox4 KO mice (green, n = 17) at day 3, an effect that was not seen in the long-term with Nox4 KO mice (green, n = 17) and WT mice (black, n = 23) (*P < 0.05), showing the same blood flow at 28 d after ischemia. (E) No significant differences in infarct size 4 wk after MI between Nox4 KO (red, n = 25) and WT mice (white, n = 26). (F) Ejection fraction decreased after MI with no significant change between Nox4 KO (red, n = 23) and WT mice (black, n = 21). (G) Left ventricular function was not different between Nox4 KO (red, n = 22) and WT mice (black, n = 20). Representative staining pictures are shown above each graph.
Fig. 2.
Fig. 2.
Validation of cell-specific NOX4 deletion in mice in endothelial, neuronal, and SMCs. (A, Left) Main cellular components of the neurovascular unit are included in the scheme. NOX4 is predominantly expressed in some components of the neurovascular unit such as endothelial cells (green), neurons (green), and pericytes (green) rather than astrocytes (gray), macrophages (gray), and microglia (gray). In fact, NOX4 play an important role in both BBB leakage after stroke (red circle on left) and neuron-derived excitotoxicity (red circle on right). Neuronal (NeuN) and endothelial (CD31) makers are also included in red. (A, Right) Due to the lack of SMCs (green) in the brain, carotid artery tissue was needed for the cell-specific Nox4 KO mice validation. SMC-specific marker (αSMA) is in red. (B, Left, first row) Immunohistochemistry (IHC) of brain tissue from a WT animal shows NOX4 expression (green) in neurons (top and bottom arrowheads) and endothelial cells (middle arrow). (B, Left, second row) IHC shows no expression of endothelial NOX4 in eNox4 KO (see merged panels) while NOX4 is still expressed in neurons (arrows). (B, Left, third row) Neuronal NOX4 is not expressed (green, all arrows) where neurons are detected by the specific tissue marker NeuN (red). (B, Left, fourth row) sNOX4 KO presents NOX4 expression (green) in both neuronal (arrow) and endothelial cells (arrowhead). Since specific expression of NOX4 in SMCs is not possible to detect in brain tissue, carotid tissue is used. (B, Right, first row) Carotid artery sections from WT mice show SMCs (red) and NOX4 (green) expression. (B, Right, second row) Carotid tissue from sNOX4 KO animals show no expression of NOX4 (green) in SMCs in comparison with WT sections. DNA was visualized using Hoechst dye.
Fig. 3.
Fig. 3.
Endothelial and neuronal, but not SMC-specific NOX4 KO reduces brain infarct and neurological scores. (A) eKO (dark blue) and nKO (light blue) show smaller infarct sizes compared with WT mice (white) (***P < 0.001, n = 23), sKO mice (cyan) did not show decreased infarcts (n = 12). Complete sets of brain slices from a representative animal (TTC staining) are shown above the graph. (B) Neurological outcome was improved in eKO and nKO in comparison with WT mice (**P < 0.01, n = 23). However, no protection on neurological function was observed in sKO (n = 12). (C) Motor function was also enhanced in eKO and nKO in comparison with WT mice (***P < 0.001, n = 23), but not in sKO mice (*P < 0.05). The n/sWT mice were treated with tamoxifen based on their respective n/sKO mice. The eWT mice were not treated since eKO have a constitutive deletion.
Fig. 4.
Fig. 4.
Contribution of endothelial and neuronal NOX4 to BBB breakdown, neuronal apoptosis, and ROS formation. (A) BBB integrity as assessed by Evans blue extravasation was preserved in the eKO (dark blue) but not in the nKO (light blue) at day 1 after 1 h of tMCAO (*P < 0.05, n = 6). Complete set of brain slices from a representative animal are shown above the graph. (B) nKO presented fewer apoptotic cells in comparison with nWT (*P < 0.05, n = 5) while no effect was shown in eKO mice (n = 5). Representative staining panels are shown above the bar graph. (C) Both eKO and nKO mice showed decreased oxidative stress compared with their respective WT littermates (***P < 0.001, n = 5). Representative staining pictures are shown above the graph.
Fig. 5.
Fig. 5.
Validation of NOX4 in a second animal species by using tMCAO in NOX4 KO rats and NOX4 inhibitors in hippocampal brain slices subjected to OGD. (A) Similarly to the mouse model, occlusion of the middle cerebral artery was performed in WT and Nox4 KO rats. Rat hippocampal brain slices were subjected to oxygen and glucose deprivation. After treatment, cell viability and ROS formation (CA3) were measured. (B) Infarct volume in Nox4 KO rats was decreased compared with the WT littermate [*P < 0.05, n = 11 (WT) and n = 9 (KO)]. Complete sets of brain slices from a representative animal (TTC staining) are shown above the graph. (C) Cell death (#P < 0.05) was significantly reduced in hippocampal brain slices treated with 0.1 μM GKT136901 and 10 μM VAS2870 as NOX inhibitors (*P < 0.05, **P < 0.01, n = 6). (D) ROS formation (###P < 0.001) was also decreased after NOX inhibition (*P < 0.05, n = 5).

Similar articles

Cited by

References

    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. - PMC - PubMed
    1. Radermacher KA, et al. Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress. Antioxid Redox Signal. 2013;18:1418–1427. - PMC - PubMed
    1. Stankowski JN, Gupta R. Therapeutic targets for neuroprotection in acute ischemic stroke: Lost in translation? Antioxid Redox Signal. 2011;14:1841–1851. - PMC - PubMed
    1. Casas AI, et al. Reactive oxygen-related diseases: Therapeutic targets and emerging clinical indications. Antioxid Redox Signal. 2015;23:1171–1185. - PMC - PubMed
    1. Dao VT-V, et al. Pharmacology and clinical drug candidates in redox medicine. Antioxid Redox Signal. 2015;23:1113–1129. - PMC - PubMed

Publication types

MeSH terms

Substances